Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2013) 31 P129 | DOI: 10.1530/endoabs.31.P129

Colchester General Hospital, Colchester, UK.


Insulin pump is one of the treatment options for patients with type 1 diabetes mellitus. In July 2008, NICE has issued Technological Appraisal (TA 151) regarding insulin pump therapy guidance.

Objective of the audit: To measure current practice in Colchester General Hospital in continuous subcutaneous insulin infusion – CSII (insulin pump) for the treatment of diabetes mellitus against the recommendations in the technological appraisal (TA 151).

Methodology: Review of patients’ notes.

Summary of findings: • Mean age of the patients is 43.1 (range 18–73) years.

• 27 females and 14 males patients are on CSII.

• The average duration of diabetes in these 41 patients is 25.7 (range 5–47) years.

• The average duration on CSII is 3.15 (range 1–7) years.

•Reason for starting on CSII – 25 patients with hyperglycaemia, 12 patients with hypoglycaemia and four patients with both reasons.

•CSII was initiated in all patients (100%) by a trained specialist team.

•The specialist team provided structured education programme and advice on diet, lifestyle and exercise appropriate for people using CSII in all patients (100%).

•27 patients (66%) have improved glycaemic control (>0.5% HbA1c reduction) 1 year after CSII.

•Six patients (43%) out of 14 patients assessed have reduced number of hypoglycaemia or improved in hypoglycaemia awareness.

•Twenty patients (49%) have lost weight 1 year after CSII.

Conclusion: Overall, the current practice in Colchester General Hospital in CSII therapy (insulin pump) for the treatment of diabetes mellitus is in line with the recommendations set by NICE’s TA 151.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts